Bladder-Sparing cancer combo shows promise in early trial
NCT ID NCT01495676
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study tested whether adding gemcitabine to standard chemoradiation (cisplatin plus radiation) could help people with muscle-invasive bladder cancer avoid bladder removal. It included 69 adults with cancer that had not spread. The goal was to see if the new combination improved how long patients lived without their cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRLC GF Leclerc
Dijon, 21000, France
-
CRLC Val d'Aurelle-Paul Lamarque
Montpellier, 34000, France
-
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, 54511, France
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Francois Baclesse
Caen, 14000, France
-
Centre azuréen de Cancérologie
Mougins, 06250, France
-
Clinique Patseur
Toulouse, 31300, France
-
HEGP
Paris, 75015, France
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hopital saint Louis
Paris, 75010, France
-
Institut Bergonié
Bordeaux, 33000, France
-
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, 42705, France
Conditions
Explore the condition pages connected to this study.